nodes	percent_of_prediction	percent_of_DWPC	metapath
Cidofovir—TYMP—adrenal cortex—polycystic ovary syndrome	0.0447	0.142	CbGeAlD
Cidofovir—Body temperature decreased—Metformin—polycystic ovary syndrome	0.0401	0.0585	CcSEcCtD
Cidofovir—Hypothermia—Metformin—polycystic ovary syndrome	0.0401	0.0585	CcSEcCtD
Cidofovir—TYMP—endometrium—polycystic ovary syndrome	0.0399	0.127	CbGeAlD
Cidofovir—TYMP—uterus—polycystic ovary syndrome	0.0368	0.117	CbGeAlD
Cidofovir—TYMP—pituitary gland—polycystic ovary syndrome	0.0361	0.115	CbGeAlD
Cidofovir—TYMP—adipose tissue—polycystic ovary syndrome	0.036	0.115	CbGeAlD
Cidofovir—Nail disorder—Metformin—polycystic ovary syndrome	0.0347	0.0505	CcSEcCtD
Cidofovir—TYMP—adrenal gland—polycystic ovary syndrome	0.0323	0.103	CbGeAlD
Cidofovir—TYMP—female gonad—polycystic ovary syndrome	0.0301	0.0959	CbGeAlD
Cidofovir—TYMP—vagina—polycystic ovary syndrome	0.0299	0.0953	CbGeAlD
Cidofovir—TYMP—endocrine gland—polycystic ovary syndrome	0.028	0.0892	CbGeAlD
Cidofovir—Accidental injury—Metformin—polycystic ovary syndrome	0.0254	0.037	CcSEcCtD
Cidofovir—Neuropathy—Metformin—polycystic ovary syndrome	0.0211	0.0308	CcSEcCtD
Cidofovir—Ear pain—Metformin—polycystic ovary syndrome	0.0191	0.0279	CcSEcCtD
Cidofovir—Injury—Metformin—polycystic ovary syndrome	0.0178	0.0259	CcSEcCtD
Cidofovir—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.0167	0.0244	CcSEcCtD
Cidofovir—Migraine—Metformin—polycystic ovary syndrome	0.0161	0.0234	CcSEcCtD
Cidofovir—Dehydration—Metformin—polycystic ovary syndrome	0.0152	0.0221	CcSEcCtD
Cidofovir—Pancreatitis—Metformin—polycystic ovary syndrome	0.0138	0.0202	CcSEcCtD
Cidofovir—Neutropenia—Metformin—polycystic ovary syndrome	0.0132	0.0192	CcSEcCtD
Cidofovir—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.0123	0.018	CcSEcCtD
Cidofovir—Rhinitis—Metformin—polycystic ovary syndrome	0.0113	0.0165	CcSEcCtD
Cidofovir—Hepatitis—Metformin—polycystic ovary syndrome	0.0113	0.0165	CcSEcCtD
Cidofovir—Oedema peripheral—Metformin—polycystic ovary syndrome	0.0111	0.0162	CcSEcCtD
Cidofovir—Eye disorder—Metformin—polycystic ovary syndrome	0.0106	0.0154	CcSEcCtD
Cidofovir—Flushing—Metformin—polycystic ovary syndrome	0.0105	0.0153	CcSEcCtD
Cidofovir—Angiopathy—Metformin—polycystic ovary syndrome	0.0102	0.0149	CcSEcCtD
Cidofovir—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.0102	0.0148	CcSEcCtD
Cidofovir—Chills—Metformin—polycystic ovary syndrome	0.0101	0.0148	CcSEcCtD
Cidofovir—Flatulence—Metformin—polycystic ovary syndrome	0.00969	0.0141	CcSEcCtD
Cidofovir—Dysgeusia—Metformin—polycystic ovary syndrome	0.00963	0.014	CcSEcCtD
Cidofovir—Muscle spasms—Metformin—polycystic ovary syndrome	0.00945	0.0138	CcSEcCtD
Cidofovir—Tremor—Metformin—polycystic ovary syndrome	0.00921	0.0134	CcSEcCtD
Cidofovir—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00912	0.0133	CcSEcCtD
Cidofovir—Malaise—Metformin—polycystic ovary syndrome	0.00887	0.0129	CcSEcCtD
Cidofovir—Syncope—Metformin—polycystic ovary syndrome	0.00882	0.0128	CcSEcCtD
Cidofovir—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00864	0.0126	CcSEcCtD
Cidofovir—Hypertension—Metformin—polycystic ovary syndrome	0.00849	0.0124	CcSEcCtD
Cidofovir—Myalgia—Metformin—polycystic ovary syndrome	0.00837	0.0122	CcSEcCtD
Cidofovir—Chest pain—Metformin—polycystic ovary syndrome	0.00837	0.0122	CcSEcCtD
Cidofovir—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00831	0.0121	CcSEcCtD
Cidofovir—Discomfort—Metformin—polycystic ovary syndrome	0.00827	0.0121	CcSEcCtD
Cidofovir—Oedema—Metformin—polycystic ovary syndrome	0.00802	0.0117	CcSEcCtD
Cidofovir—Infection—Metformin—polycystic ovary syndrome	0.00797	0.0116	CcSEcCtD
Cidofovir—Shock—Metformin—polycystic ovary syndrome	0.00789	0.0115	CcSEcCtD
Cidofovir—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00787	0.0115	CcSEcCtD
Cidofovir—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00786	0.0114	CcSEcCtD
Cidofovir—Skin disorder—Metformin—polycystic ovary syndrome	0.00779	0.0114	CcSEcCtD
Cidofovir—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00776	0.0113	CcSEcCtD
Cidofovir—Anorexia—Metformin—polycystic ovary syndrome	0.00765	0.0111	CcSEcCtD
Cidofovir—Hypotension—Metformin—polycystic ovary syndrome	0.0075	0.0109	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00731	0.0107	CcSEcCtD
Cidofovir—Paraesthesia—Metformin—polycystic ovary syndrome	0.00721	0.0105	CcSEcCtD
Cidofovir—Dyspnoea—Metformin—polycystic ovary syndrome	0.00715	0.0104	CcSEcCtD
Cidofovir—Somnolence—Metformin—polycystic ovary syndrome	0.00713	0.0104	CcSEcCtD
Cidofovir—Dyspepsia—Metformin—polycystic ovary syndrome	0.00706	0.0103	CcSEcCtD
Cidofovir—Decreased appetite—Metformin—polycystic ovary syndrome	0.00698	0.0102	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00693	0.0101	CcSEcCtD
Cidofovir—Constipation—Metformin—polycystic ovary syndrome	0.00686	0.01	CcSEcCtD
Cidofovir—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00661	0.00963	CcSEcCtD
Cidofovir—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00656	0.00956	CcSEcCtD
Cidofovir—Urticaria—Metformin—polycystic ovary syndrome	0.00637	0.00929	CcSEcCtD
Cidofovir—Abdominal pain—Metformin—polycystic ovary syndrome	0.00634	0.00924	CcSEcCtD
Cidofovir—Asthenia—Metformin—polycystic ovary syndrome	0.00576	0.00839	CcSEcCtD
Cidofovir—Pruritus—Metformin—polycystic ovary syndrome	0.00568	0.00827	CcSEcCtD
Cidofovir—Diarrhoea—Metformin—polycystic ovary syndrome	0.00549	0.008	CcSEcCtD
Cidofovir—Dizziness—Metformin—polycystic ovary syndrome	0.00531	0.00773	CcSEcCtD
Cidofovir—Vomiting—Metformin—polycystic ovary syndrome	0.0051	0.00743	CcSEcCtD
Cidofovir—Rash—Metformin—polycystic ovary syndrome	0.00506	0.00737	CcSEcCtD
Cidofovir—Dermatitis—Metformin—polycystic ovary syndrome	0.00505	0.00737	CcSEcCtD
Cidofovir—Headache—Metformin—polycystic ovary syndrome	0.00503	0.00732	CcSEcCtD
Cidofovir—Nausea—Metformin—polycystic ovary syndrome	0.00477	0.00694	CcSEcCtD
